Identifiers
HUGO:CCL17
Maps_Modules
HMC:TUMOR_PROMOTING_INFLAMMATION
HMC:ACTIVATING_INVASION_AND_METASTASIS
Cancer Associated Fibroblasts / CYTOKINES_CHEMOKINES_PRODUCTION
Cancer Associated Fibroblasts / TREG_MODULATORS
HMC:AVOIDING_IMMUNE_DESTRUCTION
Innate Immunity / RECRUITMENT_OF_IMMUNE_CELLS
References
PMID:12642832
Some subpopulations of fibroblasts could express IL17 after IL4/IL13 + TNF stimulation
The combination of TNF-alpha with either IL-4 or IL-13, however, markedly increased both TARC release and the abundance of TARC mRNA in corneal and dermal fibroblasts, but not in lung fibroblasts.
PMID:24127572
CCL17 and CCL22 have common receptor ccr4
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans.
NEUTROPHIL
PMID:26966341, PMID:24501019
TANs from established tumors produce CCL17 or CCL22, recruiting immunosuppressive regulatory T cells (Tregs) with defective cytotoxic functions into the tumor and leading to suppression of antitumoral immunity